A national survey of clinician's knowledge of and attitudes towards implantable cardioverter defibrillators

Europace

Volumn 11, Issue 10, 2009, Pages 1313-1316

  McHale, Ben ^a   Harding, Scott A ^b   Lever, Nigel A ^c,d   Larsen, Peter D ^e  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b WELLINGTON HOSPITAL   (New Zealand)

^c AUCKLAND CITY HOSPITAL   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e NONE

Author keywords

Implantable cardioverter defibrillators; Sudden cardiac death; Survey

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; FUNDING; HEALTH SURVEY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; NEW ZEALAND; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; SECONDARY PREVENTION;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; DATA COLLECTION; DEFIBRILLATORS, IMPLANTABLE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; NEW ZEALAND; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS;

EID: 70349483978     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup236     Document Type: Article

References (16)

1. The antiarrhythmics versus implantable defibrillators (AVID) investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-1583
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-237
4. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-e62.
5. Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. The task force for cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace 2007;9:959-998
6. Larsen PD, De Silva P, Lever NA. Implantable cardioverter defibrillator therapy in New Zealand. Heart Lung Circ 2008;17S:5.
7. Group NDS. Heart rhythm devices: UK National Survey 2007. http://www.ic.nhs. uk/ (1 April 2009, date last accessed).
8. Chase D, Roderick PJ, Burnley H, Gallagher PJ, Roberts PR, Morgan JM. Is there unmet need for implantable cardioverter defibrillators? Findings from a postmortem series of sudden cardiac death. Europace 2008;10:741-746
9. Plummer CJ, John Irving R, McComb JM. The incidence of implantable cardiover-ter defibrillator indications in patients admitted to all coronary care units in a single district. Europace 2005;7:266-272
10. Cunningham AD, Plummer CJ, McComb JM, Lord SW, Cunningham MW, Toussaint JM et al. The implantable cardioverter-defibrillator: postcode prescribing in the UK 1998-2002. Heart 2005;91:1280-1283
11. Mond HG, Whitlock RM. The Australian and New Zealand cardiac pacing and implantable cardioverter-defibrillator survey: calendar year 2005. Heart Lung Circ 2008;17:85-89
12. Proclemer A, Ghidina M, Cicuttini G, Gregori D, Fioretti PM. Impact of the main implantable cardioverter-defibrillator trials for primary and secondary prevention in Italy: a survey of the national activity during the years 2001-2004. Pacing Clin Electrophysiol 2006;29:S20-S28.
13. The Danish Pacemaker and ICD Registry. http://www.pacemaker.dk/ (1 April 2009, date last accessed).
14. OECD. OECD Heatlh Data 2008. http://www.oecd.org (1 April 2009, date last accessed).
15. Caro JJ, Ward A, Deniz HB, O'Brien JA, Ehreth JL. Cost-benefit analysis of preventing sudden cardiac deaths with an implantable cardioverter defibrillator versus amiodarone [see comment]. Value Health 2007;10:13-22.
16. Larsen G, Hallstrom A, McAnulty J, Pinski S, Olarte A, Sullivan S et al. Cost effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the antiarrhythmics versus implantable defibrillators (AVID) economic analysis substudy. Circulation 2002;105:2049-2057